))
Ben Orsburn and Ben Neely co-host a podcast series in a “fireside chat” format with prestigious proteomics researchers. The guests are great, the hosts are questionable.
…
continue reading
Speaking of Mol Bio, a podcast series from Thermo Fisher Scientific, discusses trending applications in science and the molecular biology aspects of those applications. Our hosts delves in to deep discussion with CEOs, R&D scientists, researchers, and key opinion leaders across the globe. Speaking of Mol Bio helps scientific curious people - from all scientific and non-scientific backgrounds - understand how modern molecular biology applications can help push the boundaries in medicine, scie ...
…
continue reading
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is p ...
…
continue reading
‘Translating Proteomics’ explores the science of proteomics and its growing impact on biological research, biomarker discovery, drug development, food and energy security, and a range of other timely topics. Hosts Parag Mallick Ph.D. and Andreas Huhmer Ph.D. of Nautilus Biotechnology aim to share their perspectives on important issues in proteomics, deepen your love of science, and prompt you to question assumptions about what may be possible.
…
continue reading
Welcome to Talking Techniques! In this Podcast BioTechniques Digital Editor Tristan Free, interviews researchers at the forefront of their fields about the latest breakthroughs, controversies and conversations in the life sciences. From CRISPR to COVID-19, organoids to the microbiome, this podcast will explore the latest developments in the lab and interesting applications of techniques, while trying to determine how we can drive science forward in progressive and inventive ways. Hosted on A ...
…
continue reading
The Journal of Proteome Research integrates the fields of chemistry, mathematics, applied physics, biology, and medicine in order to better understand the function of proteins in biological systems.
…
continue reading
Proteomics in Proximity discusses the intersection of proteomics with genomics for drug target discovery, the application of proteomics to reveal disease biomarkers, and current trends in using proteomics to unlock biological mechanisms. Co-hosted by Olink's Dale Yuzuki, Cindy Lawley and Sarantis Chlamydas.
…
continue reading
Exploring all things genetics. Dr Patrick Short, University of Cambridge alumnus and CEO of Sano Genetics, analyses the science, interviews the experts, and discusses the latest findings and breakthroughs in genetic research. To find out more about Sano Genetics and its mission to accelerate the future of precision medicine visit: www.sanogenetics.com
…
continue reading
Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.
…
continue reading
Interviews and Discussions With Fascinating People Who are Creating A Better Tomorrow For All Of Us Host - Ira S. Pastor
…
continue reading
Nextflow is the leading workflow orchestrator for bioinformaticians, data scientists, and professionals in computational biology and genetics. Stay informed with the latest updates, expert interviews, and insights from the Nextflow ecosystem. Follow us on Twitter @nextflowio and YouTube @Nextflow.
…
continue reading
The PROTEOMICS podcast is a free audio show featuring top articles from PROTEOMICS (www.proteomics-journal.com), one of the key journals in proteomic research. Listen every month to interviews with leading scientists around the world to open up the fascinating world of proteomics through their ideas and research. Get to know the PROTEOMICS family with the new addition to the podcast featuring Clinical Applications, providing insight into the application of proteomics to the study of human di ...
…
continue reading
On this podcast leading scientist, clinicians and entrepreneurs share their thoughts on the progress of personalized medicine. With our guests, we discuss new technologies for targeted treatments and diagnostics, their benefits for patients and clinicians and related implementation challenges.
…
continue reading
The vast field of sleep medicine is always evolving. Listen to Talking Sleep, a podcast of the American Academy of Sleep Medicine (AASM), to keep up on the latest developments in clinical sleep medicine and sleep disorders. Our host, Dr. Seema Khosla, medical director of the North Dakota Center for Sleep in Fargo, will take an in-depth look at issues impacting the diagnosis and treatment of sleep disorders. Episodes will feature conversations with clinicians, researchers, sleep team members ...
…
continue reading
Welcome to Biocanic’s Health Intelligence Exchange community, where leading practitioners in integrative health approaches will discuss how they solve the most challenging and common health issues. These regular Q&A discussions are designed to take a deep dive into case studies and integrative approaches in order to elevate the collective knowledge of both experienced, and new practitioners alike. Biocanic’s Health Intelligence Exchange: Your community for functional medicine.
…
continue reading
Inside Biotech is an exciting podcast from BCLA, which focuses on the science behind SoCal’s most innovative new biotech companies. This semi-monthly podcast, hosted by Gabriella Rubert, Ph.D. Candidate at UCLA and Podcast Lead at BCLA, is the perfect way for anyone interested in LA’s biotech community to stay informed about current progress and developments. Episodes feature conversations with scientists, entrepreneurs, investors, and more about the cutting-edge science that goes on inside ...
…
continue reading
After spending time in academia and exploring the unknown, the industry often seems too limited scientifically to those finishing a PhD. We will explore the bridge between the industry and academia to understand how basic scientific findings take shape into products and strategies. We will also follow the career paths of researchers who are in academia or outside of it, professionals that made their choice, followed it through and come to us to tell all about it. Academia or not? And if not, ...
…
continue reading
Welcome to Bio Bytes! Tune in for interviews with prominent scientists working at the intersection of Biology, Engineering, Medicine, Computer Science, and Mathematics. Check out our sister podcast "BioWorks" (https://anchor.fm/bioworks) for great discussions on life science-related business, investing, and policy. To support our podcast: https://securepay.cuit.columbia.edu/payment/pub/sponsor-sbi/https://securepay.cuit.columbia.edu/payment/pub/sponsor-sbi/ Please email sophiadeng0321@icloud ...
…
continue reading
1
Advancing Drug Discovery with Cutting-Edge AI & Team Synergy: Fabrice Chouraqui, CEO of Cellarity
31:40
31:40
Play later
Play later
Lists
Like
Liked
31:40
Synopsis:Step into the future of biotech as host Rahul Chaturvedi delves into an exclusive conversation with Fabrice Chouraqui, CEO of Cellarity, as he unveils the groundbreaking ways AI is revolutionizing drug discovery. Fabrice will take you behind the scenes of Cellarity’s trailblazing approach, revealing how their pioneering technology is accel…
…
continue reading
1
Vid Desai - Chief Information Officer, Office of Digital Transformation, U.S. Food and Drug Administration - Unlocking Potential, Leading Transformation
1:04:26
1:04:26
Play later
Play later
Lists
Like
Liked
1:04:26
Send us a Text Message. Vid Desai is Chief Information Officer, Office of Digital Transformation (ODT), at the U.S. Food And Drug Administration (FDA), where he sets and leads the agency’s Information Technology (IT) strategy, as well as the agency’s enterprise IT, data management, and cybersecurity. (https://www.fda.gov/about-fda/fda-organization/…
…
continue reading
1
mRNA Upstarts With Radar Therapeutics' Sophia Lugo and Eerik Kaseniit, Ph.D.
1:03:07
1:03:07
Play later
Play later
Lists
Like
Liked
1:03:07
We love to hear from our listeners. Send us a message. Guest co-host Anna Rose Welch of Advancing RNA fame joins us on this week’s Business of Biotech podcast for a conversation with the leaders of RNA upstart Radar Therapeutics. The company’s co-founders, Eerik Kaseniit, Ph.D. (CSO & President) and Sophia Lugo (CEO), are making waves in the mRNA t…
…
continue reading
1
EP 148: Advancing veteran health through the Million Veteran Program with Dr. Mike Gaziano, professor of medicine at Harvard Medical School
35:13
35:13
Play later
Play later
Lists
Like
Liked
35:13
0:00 Intro 2:00 Mike’s career prior to the Million Veteran Program (MVP), how Mike got to work on MVP, and important milestones in the project's evolution 8:30 Future goals for the Million Veteran Program in expanding and diversifying the research cohort 11:00 The roles of various omics in advancing the project's development 14:30 The most meaningf…
…
continue reading
1
Dr. Lily Brown, Ph.D. - Director - Center for the Treatment and Study of Anxiety, Perelman School of Medicine, University of Pennsylvania - World Leading Anxiety Disorder Research
54:19
54:19
Play later
Play later
Lists
Like
Liked
54:19
Send us a Text Message. Dr. Lily Brown, Ph.D., is an Assistant Professor of Psychology in Psychiatry and Director at the Center for the Treatment and Study of Anxiety, Perelman School of Medicine, at University of Pennsylvania ( https://www.med.upenn.edu/ctsa/LilyBrownPhD.html ). Dr. Brown received her Bachelors of Science Degree in Psychology at D…
…
continue reading
As part of the non-sponsored sporadic "B-sides" series*, Ben and Ben sit down and talk with our first return guest, Dr. Rachel Lance (Ep 21). (* this series is where we put guests we want to talk to but who do not fit within any sponsored series, but is still proteomics.... mostly)
…
continue reading
1
Prof. Dr. Dan Blumberg Ph.D. - Vice-President for Regional and Industrial Development - Ben-Gurion University of the Negev - Chair, Israel Space Agency - Planetary Science Innovation For All Humanity
1:04:37
1:04:37
Play later
Play later
Lists
Like
Liked
1:04:37
Send us a Text Message. Professor Dr. Dan Blumberg, Ph.D. is the Vice-President for Regional and Industrial Development at Ben-Gurion University of the Negev ( BGU - https://www.blumberg.bgu.ac.il/ ), an elected Member of the International Academy of Astronautics, and Chair of the Israel Space Agency ( https://www.space.gov.il/en ), a position he w…
…
continue reading
1
Dr. Parag Mallick, PhD - Co-Founder, Nautilus Biotechnology - Unlocking The Complexity Of The Proteome For A New Era Of Scientific Discovery
54:36
54:36
Play later
Play later
Lists
Like
Liked
54:36
Send us a Text Message. Dr. Parag Mallick, Ph.D. is an Associate Professor at Stanford University ( https://profiles.stanford.edu/parag-mallick ) and Co-Founder of Nautilus Biotechnology ( https://www.nautilus.bio/ ), a development stage life sciences company, engaged in creating a platform technology for quantifying and unlocking the complexity of…
…
continue reading
1
Skills-based teaching and microcredentialing in STEM
54:22
54:22
Play later
Play later
Lists
Like
Liked
54:22
This episode of Talking Technique deviates slightly from specific lab technologies to instead discuss techniques and methods we use for teaching and testing life sciences. To do this, I’m speaking to two pioneers of unconventional teaching and testing approaches to STEM education. Angela Consani is the Co-Founder and CEO of the Bioscience Core Skil…
…
continue reading
1
Episode 44: Regulatory revolution - Open source software in pharma and clinical settings.
36:15
36:15
Play later
Play later
Lists
Like
Liked
36:15
In episode 44 of the Nextflow Channels podcast, Phil Ewels welcomes Alex Pelzer— a key figure in the Nextflow and nf-core community. Alex shares his journey from academia to the pharmaceutical industry, highlighting the critical role of regulatory frameworks in bioinformatics. 🌟 Key Highlights: The transition from working at QBiC to Boehringer Inge…
…
continue reading
1
Steering Through Setbacks with AVEO Oncology's Michael Bailey
58:06
58:06
Play later
Play later
Lists
Like
Liked
58:06
We love to hear from our listeners. Send us a message. For all the drug commercialization successes he's played a leading hand in during his tenures at GSK, Genentech, and ImClone—Androderm, Augmentin, necitumumab, and Erbitux among them—Michael Bailey concedes that he's likely better known for his failures. After hearing his stories on this episod…
…
continue reading
1
Silent and sleepy: The use of wake-promoting medications in well-treated OSA
54:46
54:46
Play later
Play later
Lists
Like
Liked
54:46
Excessive daytime sleepiness is a significant problem for many people who have obstructive sleep apnea (OSA), and persistent sleepiness occurs in some patients despite effective treatment of OSA. Dr. Kingman Strohl and Dr. Lucas Donovan discuss this common clinical scenario, provide tips for the evaluation of persistent sleepiness, and talk about t…
…
continue reading
1
Ronnie Vasishta - Senior Vice President, Telecom, NVIDIA - Intelligently Connecting Intelligence - Accelerating Development Of 6G Technologies For A Hyper-Intelligent World
41:41
41:41
Play later
Play later
Lists
Like
Liked
41:41
Send us a Text Message. Ronnie Vasishta is Senior Vice President, Telecom at NVIDIA ( https://blogs.nvidia.com/blog/author/ronniev/ ), where he leads all aspects of NVIDIA's telecom business from business management to product go-to-market strategy. His organization is responsible for defining and architecting next-generation virtualized, open 5G a…
…
continue reading
1
Redefining Dementia Care: CervoMed's Bold Journey with CEO John Alam
24:38
24:38
Play later
Play later
Lists
Like
Liked
24:38
Synopsis:Get ready for an insightful conversation as host Rahul Chaturvedi connects with John Alam, CEO of CervoMed, to uncover the revolutionary advancements transforming dementia treatment, with a spotlight on Dementia with Lewy Bodies (DLB). John shares his remarkable journey from practicing medicine to leading cutting-edge biotech innovations, …
…
continue reading
1
EP 147: From research to delivering precision medicine in the clinic with Scott Weiss, Professor of Medicine at Harvard University
37:19
37:19
Play later
Play later
Lists
Like
Liked
37:19
0:00 Intro to The Genetics Podcast 01:00 Welcome to Scott 01:55 Scott’s career highlights to date, ranging from epidemiology to the genetics of asthma and chronic obstructive pulmonary disease (COPD) 04:56 How and why Scott decided to transition into genetics 06:30 The advances in our understanding of the genetics of asthma and COPD over the past 2…
…
continue reading
There are all sorts of molecular tests to tell if you’re infected with something specific, but what do you use when you’re not sure what you might have? You might use a thermometer as a first step, but wouldn’t it be nice if that thermometer was a bit more high tech? In this episode we meet Dr. Nick Meyerson, CEO and co-founder of Darwin Bioscience…
…
continue reading
1
What in the 'omics? All things Genomics, Proteomics, and Metabolomics! | Dr. Anil Bajnah, MD
58:27
58:27
Play later
Play later
Lists
Like
Liked
58:27
Join us with guest Dr. Anil Bajnath, MD, and Jeremy discuss What in the 'omics? All things Genomics, Proteomics, and Metabolomics! Dr. Anil Bajnath is a Board-Certified Family Physician and author of "The Longevity Equation." He serves as Adjunct Faculty at George Washington University School of Medicine, heads the Institute for Human Optimization …
…
continue reading
1
Leading From Within with ISCT & Kiji's Miguel Forte, M.D.
59:37
59:37
Play later
Play later
Lists
Like
Liked
59:37
We love to hear from our listeners. Send us a message. He's been a big pharma executive. He's a multi-time biotech founder and current biotech CEO. He was once a regulator. He's a physician. He serves on multiple boards. And as of this summer, he's president of one of the most influential global organizations dedicated to the advance of cell and ge…
…
continue reading
1
Prof. Dr. Alan Widgerow - Division Chief, Center for Tissue Engineering, University of California, Irvine - Chief Scientific Officer, Galderma - Innovation At The Frontiers Of Aesthetic And Regenerative ...
1:03:10
1:03:10
Play later
Play later
Lists
Like
Liked
1:03:10
Send us a Text Message. Prof. Dr. Alan Widgerow, MBBCh, FCS, MMed, FACS, is Division Chief, Research, Center for Tissue Engineering ( https://sites.uci.edu/ctelab/team/ ) and Adjunct Professor Plastic Surgery, Dept of Plastic Surgery, University of California, Irvine ( https://faculty.uci.edu/profile/?facultyId=6048 ) and Chief Scientific Officer a…
…
continue reading
1
Optimizing Your Business and Websites to Increase Traffic and Conversions | Lauren Powers
56:16
56:16
Play later
Play later
Lists
Like
Liked
56:16
Join us with guest Lauren Powers and Jeremy discuss Optimizing Your Business and Websites to Increase Traffic and Conversions. Lauren Powers is the President at Microsite Digital Marketing agency. She currently leads an amazing team that supports health entrepreneurs grow their business through online marketing and sales coaching. She is a business…
…
continue reading
1
Mastering the Art and Science of Healing through Restorative Wellness Solutions
1:01:08
1:01:08
Play later
Play later
Lists
Like
Liked
1:01:08
This week guest Margaret Floyd Barry and Jeremy discuss Mastering the Art and Science of Healing through Restorative Wellness Solutions. Margaret is a functional nutritionist, writer, speaker, and educator. She joined the Restorative Wellness Solutions team in 2015 after taking the inaugural RWS class and transforming her practice with the applicat…
…
continue reading
1
Dr. Ryan Potts, Ph.D. - VP and Head, Induced Proximity Platform, Amgen - Leading The Next Wave Of Innovation In Drug Discovery, To Modulate Any Target, Every Time
58:32
58:32
Play later
Play later
Lists
Like
Liked
58:32
Send us a Text Message. Dr. Ryan Potts, Ph.D. is Vice President and Head, Induced Proximity Platform at Amgen ( https://www.amgen.com/science/research-and-development-strategy/multispecifics-and-other-modalities ) which is focused on novel ways to bring two or more molecules in close proximity to each other to tackle drug targets that are currently…
…
continue reading
1
EP 146: The biology of aging with Austin Argentieri, Research Fellow at Harvard Medical School, Affiliate Member of the Broad Institute, and Research Fellow at Massachusetts General Hospital
43:05
43:05
Play later
Play later
Lists
Like
Liked
43:05
0:00 Intro to The Genetics Podcast 01:00 Welcome to Austin 01:42 What is aging and how should we think about it? 03:50 Discussion of Austin’s recent breakthrough paper on aging, including the questions he set out to answer, and the outcomes of the research 06:32 How Austin’s work focuses on using large-scale population proteomics data to create acc…
…
continue reading
1
Dr. Ashwin Vasan, MD, PhD - Commissioner - NYC Dept. of Health & Mental Hygiene - Strengthening Public Health Systems For Heathier And Longer Lives
1:01:15
1:01:15
Play later
Play later
Lists
Like
Liked
1:01:15
Send us a Text Message. Dr. Ashwin Vasan, MD, PhD is the Commissioner of the New York City Department of Health and Mental Hygiene ( https://www.nyc.gov/site/doh/about/about-doh/the-commissioner.page ). Dr. Vasan is a primary care physician, epidemiologist and public health expert with nearly 20 years of experience working to improve physical and m…
…
continue reading
1
From Banking to Biotech: Renée Aguiar-Lucander, CEO of Calliditas, on Rare Disease Innovation
30:51
30:51
Play later
Play later
Lists
Like
Liked
30:51
Synopsis:Renée Aguiar-Lucander, CEO of Calliditas Therapeutics, appears on this insightful episode of Biotech 2050 with host Rahul Chaturvedi. Renée shares her unconventional journey from investment banking to biotech leadership, underscoring the crucial role of capital markets and regulatory strategies. The discussion explores the unique challenge…
…
continue reading
In this episode we explore the new features of Seqera's Data Studios and Data Explorer, with Phil Ewels, Rob Newman and Rob Syme from Seqera. Discover how to use these tools for troubleshooting Nextflow pipelines, tertiary analysis and Nextflow development. We discuss the pain points that led to the creation of Data Studios and how it's designed to…
…
continue reading
1
The Allogeneic Future with Poseida's Kristin Yarema, Ph.D.
1:04:44
1:04:44
Play later
Play later
Lists
Like
Liked
1:04:44
We love to hear from our listeners. Send us a message. Kristin Yarema, Ph.D. thinks the progress of CAR T therapeutics is allogeneic. In fact, she says CAR T-cell therapies have to become a one-to-many proposition, if their early autologous success can possibly live up to the promise of offering widespread accessibility to life-saving treatments. D…
…
continue reading
1
Cutting Through the Haze - the Use of Cannabis for Sleep and Sleep Apnea
30:20
30:20
Play later
Play later
Lists
Like
Liked
30:20
There are currently 40 states with legalized medical marijuana. Twenty-four of these also have legalized recreational marijuana. Many people report using cannabis to help them to initiate and maintain sleep. Is there any data to support this? Is cannabis safer than prescription sleep aids? What should we know about cannabis and sleep? Dr. Bhanu Pra…
…
continue reading
1
Autoimmune Innovations: Insights from Marshall Fordyce, Founder & CEO, Vera Therapeutics on Biotech
32:50
32:50
Play later
Play later
Lists
Like
Liked
32:50
Synopsis: In this engaging episode, host, Rahul Chaturvedi welcomes Marshall Fordyce, Founder and CEO of Vera Therapeutics, to discuss his transformative journey from physician to biotech entrepreneur. Marshall shares the story behind Vera Therapeutics' strategic pivot to focus on IG nephropathy and their development of atacicept, a promising B-cel…
…
continue reading
1
EP 145: Navigating rare disease drug development regulations with Daniel O’Connor
39:12
39:12
Play later
Play later
Lists
Like
Liked
39:12
0:00 Intro to The Genetics Podcast 01:00 Welcome to Daniel 02:04 Defining rare disease in the age of personalized medicine 04:57 Key touchpoints with the Medicines and Healthcare products Regulatory Agency (MHRA) when developing a new medicine 09:27 Improvements over the course of Daniel’s career when it comes to incentivizing and making the path t…
…
continue reading
1
Dr. Tim MacLeod & Dr. Vaibhav Narayan - Davos Alzheimer's Collaborative - Ending Alzheimer’s Disease Everywhere
1:12:38
1:12:38
Play later
Play later
Lists
Like
Liked
1:12:38
Send us a Text Message. The Davos Alzheimer's Collaborative ( DAC - https://www.davosalzheimerscollaborative.org/ ) is a pioneering worldwide initiative to cure Alzheimer’s disease and dementia, seeking to mirror the success of global efforts against infectious diseases such as HIV/AIDS, Covid, and Malaria. Absent effective action at scale around t…
…
continue reading
1
Expanding The Proteome with ProFound's John Lepore, M.D.
56:38
56:38
Play later
Play later
Lists
Like
Liked
56:38
We love to hear from our listeners. Send us a message. Flagship Pioneering’s ProFound Therapeutics is on to something, and it could be something big. It began with a simple question: What if more RNAs were being translated into proteins? Answering that question took ProFound deep into the translatome, where it’s now studying the full compendium of …
…
continue reading
1
EP 144: Research Roundup with Dr. Veera: breakthroughs in developmental disorders, Parkinson's, SLE, and Alzheimer's
56:48
56:48
Play later
Play later
Lists
Like
Liked
56:48
0:00 Introduction 1:40 A recurrent de novo mutation in a noncoding region of a small nucleolar RNA gene that has been identified as one of the most common causes of neurodevelopmental disorders This pathogenic variant escaped notice for years because it was not located in a protein coding region of the genome It now shows potential as a target for …
…
continue reading
1
Dr. Andrea Choe, MD, Ph.D. - CEO, Holoclara - Worm-Derived Therapeutics For Debilitating Diseases
49:22
49:22
Play later
Play later
Lists
Like
Liked
49:22
Send us a Text Message. Dr. Andrea Choe, MD, Ph.D. is the CEO and Co-Founder of Holoclara ( https://www.holoclara.com/ ), a company focused on creating novel, safe, orally bioavailable worm-derived therapeutics with a focus on indications such as allergies and autoimmune disorders. While pursuing her doctorate at the California Institute of Technol…
…
continue reading
1
Transforming Gene Therapy: Exclusive Insights from Zandy Forbes, President & CEO of MeiraGTx
50:25
50:25
Play later
Play later
Lists
Like
Liked
50:25
Synopsis:Zandy Forbes, Founder, President, and CEO of MeiraGTx, joins host Rahul Chaturvedi in this compelling episode. Zandy shares her inspiring journey from academia, where she developed a deep interest in molecular biology and genetics, to her significant role in biotech investing, and eventually leading a groundbreaking gene therapy company. S…
…
continue reading
1
Episode 42: Nextflow on the Road — ISMB 2024 in Montreal
40:04
40:04
Play later
Play later
Lists
Like
Liked
40:04
A small but intrepid team of Seqerans recently attended the ISMB 2024 conference in Montreal, a great mix of computational biology and bioinformatics with a largely academic / research-focused audience. Join Geraldine Van der Auwera, Rob Syme and Florian Wuennemann for a lively discussion about the scientific themes of the conference, their experie…
…
continue reading
1
From The Bench To The Boardroom with ImmunityBio's Enrique Diloné
1:06:39
1:06:39
Play later
Play later
Lists
Like
Liked
1:06:39
We love to hear from our listeners. Send us a message. While organic chemistry lectures caused many of his peers at NYU to wring their hands, gnash their teeth, and question life choices, then-19-year-old Enrique Diloné ate those classes for lunch. They inspired him to earn a Seton Hall Ph.D. in chemistry, and to go to work as a big bio research sc…
…
continue reading
As technology continues to permeate every aspect of our lives, the subset of sleep-related technology continues to expand. The AASM Emerging Technology committee continues to assess both clinical and consumer sleep technology. We have previously discussed consumer and clinical sleep technology that largely centered around snoring and OSA. In this e…
…
continue reading
1
EP 143: Harnessing human data in drug development with Jakob Steinfeldt, Co-Founder and Chief Scientific Officer at Pheiron
36:17
36:17
Play later
Play later
Lists
Like
Liked
36:17
0:00 Intro to The Genetics Podcast 01:00 Welcome to Jakob and background on Pheiron 02:14 What made Jakob decide to start Pheiron, what the company does, and how his scientific background inspired him to found a start-up 5:24 Jakob’s excitement and inspiration around the power and potential of machine learning 07:07 Cardiology and heart failure as …
…
continue reading
1
Biotech Breakthroughs: Jeb Keiper, CEO of Nimbus Therapeutics, Discusses Their Innovative Journey
35:03
35:03
Play later
Play later
Lists
Like
Liked
35:03
Synopsis:Dive into this episode of Biotech 2050 where host Rahul Chaturvedi interviews Jeb Keiper, CEO of Nimbus Therapeutics. Discover Jeb's fascinating journey from MIT chemist to industry leader, and the unique strategies that have driven Nimbus's success. Jeb discusses the evolution of biotech financing, the importance of taking bold risks, and…
…
continue reading
1
Dr. Abdulelah Alhawsawi, MD - CEO, Novo Genomics, Saudi Arabia - Personalized And Safe Healthcare And Wellness
1:07:20
1:07:20
Play later
Play later
Lists
Like
Liked
1:07:20
Send us a Text Message. Dr. Abdulelah Alhawsawi, MD is the CEO of Novo Genomics ( https://novogenomics.sa/ ), a company located in KSA with a vision of being the regionally trusted, globally recognized biotech leader in the field of genomics & multiomics. Dr. Alhawsawi is the former Founding Director General of the Saudi Patient Safety Center ( SPS…
…
continue reading
1
First AI Antibody In Humans with Aulos' Aron Knickerbocker
1:08:52
1:08:52
Play later
Play later
Lists
Like
Liked
1:08:52
We love to hear from our listeners. Send us a message. Data drives decision-making at Aulos Bioscience. It's also driven the career trajectory of its CEO. On this week's episode of the Business of Biotech podcast, we get an introspective walk through Aron Kinickerbocker's strategically-orchestrated career path, from his early days in the labs at Br…
…
continue reading
Plastics are a modern miracle of science that have helped deliver both convenience and life-saving solutions. However, we must now grapple with the challenge of immense amounts of plastics in our waste streams and environment. How do we best deconstruct plastics to reusable or more bio-friendly molecules? This is the exact challenge being addressed…
…
continue reading
1
Antigen validation and T-cell receptor engineering for cancer immunotherapies
19:41
19:41
Play later
Play later
Lists
Like
Liked
19:41
This episode of the Talking Techniques podcast dives into the realm of cancer immunotherapies, focusing on antigen discovery and T-cell receptor engineering for T-cell therapies. Guiding us through the field is Jim Heath, President of the Institute for Systems Biology in Seattle, where he runs the Heath Lab, investigating fundamental immunology, an…
…
continue reading
1
Dr. Vanúsia Nogueira, Ph.D. - Executive Director - The International Coffee Organization - Strengthening The Global Coffee Sector And Promoting Sustainable Expansion
45:23
45:23
Play later
Play later
Lists
Like
Liked
45:23
Send us a Text Message. Dr. Vanúsia Nogueira, Ph.D. is Executive Director of The International Coffee Organization ( ICO - https://icocoffee.org/ ), an organization focused on strengthening the global coffee sector and promoting it’s sustainable expansion in a market-based environment for the benefit of all actors in the Global Coffee Value Chain. …
…
continue reading
1
Revolutionizing Proteomics: Sujal Patel, Co-Founder & CEO of Nautilus, on Drug Development
36:55
36:55
Play later
Play later
Lists
Like
Liked
36:55
Synopsis:Sujal Patel, co-founder and CEO of Nautilus Biotechnology, discusses their innovative work in proteomics and its impact on drug development. Sujal shares his transition from tech to biotech, the formation of Nautilus with Parag Mallick, and their revolutionary approach using multi-affinity probes. The conversation highlights the importance…
…
continue reading
1
EP 142: From genome to bedside: How genetics is transforming modern medical practice with Dr. Andrea Gropman
42:45
42:45
Play later
Play later
Lists
Like
Liked
42:45
0:00 Introduction 1:40 Andrea’s background and how she got into the field of genetics, neuroimaging, and metabolic disorders 4:00 Insights into Andrea’s clinical practice, including the diverse families and patients she serves and her approach to clinical decision-making 6:30 How genetics and genomics have changed the diagnostic journey in the last…
…
continue reading
1
Dr. Oren Milstein, PhD - CEO, StemRad - Personal Radiation Protection Solutions For Earth And Space
1:02:06
1:02:06
Play later
Play later
Lists
Like
Liked
1:02:06
Send us a Text Message. Dr. Oren Milstein, Ph.D. is CEO and Board Member of StemRad ( https://stemrad.com/ ), a world leader in the provision of personal radiation protection solutions and is the first company to offer life-saving protection from penetrating ionizing radiation and is making the lives of first responders, military personnel, utility…
…
continue reading
1
Cytokines: from therapeutics to diagnostics
26:11
26:11
Play later
Play later
Lists
Like
Liked
26:11
In this episode of Talking Techniques, Ritwika Biswas, Field Application Scientist at Sino Biological US Inc. (PA, USA), discusses the use of cytokines in immunotherapy. Ritwika details the role of cytokines in the body, before going on to discuss how they can be used as therapeutics and to guide treatment decisions. Ritwika also shares how she thi…
…
continue reading
1
Dr. Jeffrey DellaVolpe, MD - Methodist Hospital, San Antonio, Texas - Saving Lives With Extracorporeal Membrane Oxygenation (ECMO) Technology
37:37
37:37
Play later
Play later
Lists
Like
Liked
37:37
Send us a Text Message. Dr. Jeffrey DellaVolpe, MD is Medical Director of the Adult Extracorporeal Membrane Oxygenation (ECMO) Program at Methodist Hospital, San Antonio, Texas. He is also the Medical Director of the Cardiovascular Intensive Care Unit at Methodist Healthcare System and the Texas IPS Critical Care Service Line ( https://texasips.com…
…
continue reading
